Background-We investigated the relationship between self-reported sleep characteristics and brachial artery flow-mediated dilation (FMD) in a community-based population. Prior studies document that sleep apnea may be related to endothelial dysfunction but disagree whether subjective reports of sleep may also reflect such associations.
INTRODUCTION
Abnormal endothelial function has been associated with sleep apnea using biochemical markers such as vascular endothelial growth factor (VEGF) 1 , declines in nitric oxide bioavailability 2 , monocyte activation 3 , and with radiologic or dynamic vascular measures such as coronary artery calcification 4 , carotid intima-media thickness 5 , and flow mediated vasodiliation 6 . Some of these alterations may even be reversible with nasal continuous positive airway pressure (CPAP) therapy 1, 2, 7 . Far more equivocal are associations between endothelial function and subjective reports of sleep duration or other aspects such as snoring or low sleep quality. For example, although laboratory-based studies of experimental sleep deprivation may increase adhesion molecules and E-selectin 8 or result in elevated blood pressures 9 , whether such relationships are also reflected in subjects' verbal reports about their own short duration of sleep remain far more dubious. Low reported sleep quality in a large population based sample 10 was reported to be unrelated to altered FMD and short reported sleep durations were unrelated to levels of endothelial progenitor cells 11 , but other studies suggest that reported (or actigraphically assessed) short sleep durations may be associated with increased carotid intima-media thickness 12, 13 or coronary artery calcification 14 . In this study, we examined self-reported, sleep-related symptoms in a community-based, non-clinic population with commonly used standardized scales and related these results to brachial artery FMD -long recognized to be the gold standard of abnormal endothelial dysfunction 15 .
METHODS

Study Sample
The sample was derived from the "Predictive Health Institute: The Center for Health Discovery and Well Being," which consists of participating Emory University and Georgia Tech University employees (mean age 48±11 years, 68% female, and 71% white.) History of diabetes and hypertension were defined with the use of anti-diabetic and antihypertensive medications respectively. Smoking history, obtained using standardized questionnaires, was defined as current or never/former (no cigarettes within the past 30 days). Height and weight were measured. Blood pressure was monitored with an automatic blood pressure monitor. The study was approved by the Emory University and Georgia Tech University Institutional Review Committees. Informed consent was obtained from all participants.
Measurement of Reported Sleep Characteristics
Participants enrolled in the study completed two questionnaires collecting data related to their sleep: the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS). The PSQI is a self-administered validated 19-item scale that assesses overall sleepquality and a wide range of sleep-related symptoms experienced during the previous 1 month 16 . The 19 items of the PSQI yield 7-component scores that reflect the frequency of sleep problems. The sum of the 7 components yields a global score that ranges from 0 to 21, with higher scores indicating poorer sleep quality. We utilized total PSQI scores, the 7 component scores, and selected item analysis of specific sleep disturbance complaints as done previously 17 . These items included self-reports of cough / snore, sleep durations, and reports of getting up at night to use the restroom -all symptoms that have been associated with sleep apnea.
The ESS measures daytime sleepiness. A summary score is derived from the likelihood of falling asleep during the daytime in eight different situations, 18 which the subject rates on a scale of 0-3 how likely they would be to doze off or fall asleep. Scores range from 0 to 24, with higher scores indicating greater daytime sleepiness.
Assessment of endothelial function
The assessment of endothelial function in this study was done via FMD. Endotheliumdependent brachial artery FMD was determined as previously described 19, 20 . Briefly, ultrasound images were obtained at baseline under standardized conditions and ≈60 seconds after induction of reactive hyperemia by 5-minute cuff occlusion of the forearm. After a 15minute period to re-establish baseline conditions, endothelium-independent dilation of the brachial artery was assessed from images obtained before and 3 to 5 minutes after administration of 0.4 mg of sublingual nitroglycerin. Images were digitized online, and arterial diameters were measured with customized software (Medical Imaging Applications, Inc) by individuals blinded to the clinical status and laboratory status of the subjects. FMD and endothelium-independent vasodilation were expressed as the percentage increase in diameter from baseline.
Statistical methods
Study variables are described as the mean ± SD (unless otherwise specified) for continuous variables or as counts or proportions for categorical variables. Age, body mass index, and FMD were treated as continuous variables. Smoking, gender, and medication use (antihypertensive drugs, glucose lowering agents) were categorical variables. Continuous variables were tested for normality with the Kolmogorov-Smirnov criterion. Skewed variables were log transformed and tested again for normality before any parametric analysis.
Univariate correlations between brachial artery FMD and measured sleep parameters were performed with Pearson correlation. Multivariate linear regression models were constructed to determine relationships between sleep and vascular function parameters before and after adjustment for age, race, gender, smoking, hypertension (defined by medication use), diabetes (defined by medication use), and body mass index. Group differences were evaluated by Student t-tests or 1-way analysis of covariance. Statistical significance was based on 2-tailed tests, and p-values ≤0.05 were considered significant. Analyses were performed with SPSS (version 17.0, SPSS, Inc., Chicago, Illinois).
RESULTS
Subject characteristics
Baseline characteristics of the 684 subjects are shown in Table 1 . Of the participants (mean age 48±11 years), 68% were female, and 71% were white. This was a relatively healthy population, as indicated by relative low rates of hypertension, diabetes, and tobacco use.
Reported Sleep
PSQI-Total PSQI scores were unrelated to brachial artery FMD (multivariate p= 0.1223), suggesting no relationship to endothelial function. Of the 7 PSQI component scores, only component 1 (sleep quality) was related to FMD and indicated that poorer subjective sleep quality was associated with lower FMD (multivariate p= 0.038). Additionally, subjects who reported coughing or snoring at least once a week had lower FMD values (6.2±3.4) when compared to those individuals who reported no such symptoms over the last month (6.9±4.3) (univariate p= 0.056) (effect size d = .20). This value maintained statistical significance after multivariate adjustment for age, gender, race, body mass index (BMI), smoking history, history of hypertension, and history of diabetes (multivariate p= 0.03) ( Figure 1) . When examining sleep duration as a continuous variable, there was a near significant association (multivariate p= 0.0671) with those subjects who obtain less sleep and lower FMD measurements. Getting up at night to use the bathroom and FMD were unrelated (multivariate p= 0.6133).
ESS-Using multivariate models comparable to those used for PSQI, higher ESS scores were associated with lower brachial artery FMD (p= 0.026) ( Figure 2 ). Interestingly, those who reported cough / snore at night had higher ESS scores (8.0±4.4) compared to those who did not (6.3±4.0) (multivariate p< 0.0001). (Table 1 ). The mean ESS score in this population is similar to those reported in other biracial populations, such as the Coronary Artery Risk Development in Young Adults (CARDIA) study 21 , although the distribution (Figure 2 ) suggests a substantial number of individuals reporting high levels of subjective daytime sleepiness, perhaps compatible with a degree of relatively restricted within the sleep population generally [22] [23] [24] .
DISCUSSION
Using a "gold standard" assessment of endothelial function in a relatively large, communitybased population with a relatively low risk factor burden, we demonstrated an association between brachial artery FMD and selected aspects of reported sleep, including subjective quality, coughing/snoring during sleep, and daytime sleepiness even after adjustment for common CVD risk factors. It may well be that reports of relatively poor sleep quality, coughing/snoring and daytime sleepiness in this study were related to lower FMD values because they serve as proxy symptoms of sleep apnea 25 . One weakness of this study is that we did not obtain measurements of sleep physiology to confirm whether this may indeed be the case. However, the apparent interaction of reported snoring and daytime sleepiness suggests that these symptoms may have additive risk. Epidemiologic studies examining sleep-related cardiovascular risk factors may well consider viewing these symptoms in tandem. The association observed between brachial artery FMD and coughing/snoring was of small magnitude (d = .20), although this effect was at least comparable to, if not larger, than the effect size noted (r 2 = .012) in a study relating brachial artery FMD to polysomnographically assessed AHI 6 . Brachial artery FMD is known to be affected beneficially by beta-blockers, perhaps by increasing nitric oxide bioavailability 26, 27 , although the relatively small number of number of patients using this drug class (n = 62) makes it unlikely this had a major impact on our results.
Our study has other weaknesses as well. Medication use served as a proxy for health conditions. Thus, a diagnosis of hypertension or diabetes was assigned on the basis of medication-use rather than by physical examination or laboratory findings. Utilization of such surrogate markers for disease is not uncommon in epidemiologic studies. In fact, several analyses have demonstrated that such reported medication use may serve as reasonable approximations for disease prevalence 28, 29 . Finally, the questionnaires used here to assess for sleep apnea (PSQI, ESS) may not be best suited for this purpose. Currently, questionnaires such as the STOP-BANG 30 or the Berlin Questionnaire 31 see widespread use, target sleep apnea symptoms per se, and may be more valid measures.
CONCLUSION
Even in the absence of measured sleep apnea, specific subjective sleep-related symptoms may be important independent correlates of endothelial dysfunction as measured by brachial artery FMD. The relationship between the Epworth Sleepiness Scale and FMD adjusted for CVD risk factors. FMD: Flow mediated dilation (%). r: Pearson's correlation coefficient; p-value is for 2-tailed test of significance. 
Participant Demographics
Demographic characteristics for the entire study cohort, subjects who report coughing or snoring during sleep, and those who did not. 
